Clinical Trial Update: Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of tivozanib with FOLFOX6 in adults with advanced colorectal cancer and other gastrointestinal cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastrointestinal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Tivozanib (tivozanib)

Snippet

Sponsor: AVEO Pharmaceuticals, Inc. | Conditions: Colorectal Cancer, Gastrointestinal Cancer | Phase 1 | Status: COMPLETED